Our DNA microarray analyses have identified several tumour suppressors as candidate downstream targets of TLX and TET3, including BTG2 and PPP2R1B (Fig. 8g), which were also upregulated upon TLX knockdown in PBT003-grafted brain tumours in NSG mice (Supplementary Fig. 8). The gene discussed is TET3; the disease is neoplasm.